CoChat

Ebola virus disease mathematical models and epidemiological parameters: a systematic review

Open access

The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.

Abstract

Ebola virus disease poses a recurring risk to human health. We conducted a systematic review (PROSPERO CRD42023393345) of Ebola virus disease transmission models and parameters published from database inception to July 7, 2023, from PubMed and Web of Science. Two people screened each abstract and full text. Papers were extracted with a bespoke Access database, 10% were double extracted. We extracted 1280 parameters and 295 models from 522 papers. Basic reproduction number estimates were highly variable, as were effective reproduction numbers, likely reflecting spatiotemporal variability in interventions. Random-effect estimates were 15·4 days (95% CI 13·2-17·5) for the serial interval, 8·5 days (7·7-9·2) for the incubation period, 9·3 days (8·5-10·1) for the symptom-onset-to-death delay, and 13·0 days (10·4-15·7) for symptom-onset-to-recovery. Common effect estimates were similar, albeit with narrower CIs. Case-fatality ratio estimates were generally high but highly variable, which could reflect heterogeneity in underlying risk factors. Although a substantial body of literature exists on Ebola virus disease models and epidemiological parameter estimates, many of these studies focus on the west African Ebola epidemic and are primarily associated with Zaire Ebola virus, which leaves a key gap in our knowledge regarding other Ebola virus species and outbreak contexts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(24)00374-8

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 PRISMA flowchart illustrating the systematic review process.
Figure 1 PRISMA flowchart illustrating the systematic review process.CC BY · PubMed Central
Figure 2 Basic reproduction numbers (R0) by outbreak. Each panel corresponds to a different outbreak of EVD with the associated EV species in brackets. Points represent central estimates, with symbol shapes corresponding to central value type. Thick coloured shaded lines represent the range of central estimates when R0 was estimated, for example, across regions or over time. Solid coloured bars represent the uncertainty around the central estimate; this was reported in different formats including standard deviation (in which case the bar represents +/- the standard deviation), 95% highest posterior density interval, range, interquartile range, 95% CrI (credible interval) and 95% CI. The x-axis has been restricted to a maximum of 10 for clarity. All parameters are from articles with a QA score of >= 50% (see appendix pp 21-23 for all R0 estimates).
Figure 2 Basic reproduction numbers (R0) by outbreak. Each panel corresponds to a different outbreak of EVD with the associated EV species in brackets. Points represent central estimates, with symbol shapes corresponding to central value type. Thick coloured shaded lines represent the range of central estimates when R0 was estimated, for example, across regions or over time. Solid coloured bars represent the uncertainty around the central estimate; this was reported in different formats including standard deviation (in which case the bar represents +/- the standard deviation), 95% highest posterior density interval, range, interquartile range, 95% CrI (credible interval) and 95% CI. The x-axis has been restricted to a maximum of 10 for clarity. All parameters are from articles with a QA score of >= 50% (see appendix pp 21-23 for all R0 estimates).CC BY · PubMed Central
Figure 3 Meta-analysis for the mean A) serial interval, B) incubation period, C) time from symptom onset to death, and D) time from symptom onset to recovery. All included studies have a QA score of >=50%. Parameters used in the meta-analyses are paired mean and standard deviation of the sample or were converted into mean and SD of the sample from the following combinations: mean and standard error, median and interquartile range, or median and range (see appendix pp 9-10). Blue squares are mean estimates from each study with 95% confidence intervals. Diamonds represent the overall mean across studies for the common and random effect models. The random effect model accounts for within-study and between-study variance.
Figure 3 Meta-analysis for the mean A) serial interval, B) incubation period, C) time from symptom onset to death, and D) time from symptom onset to recovery. All included studies have a QA score of >=50%. Parameters used in the meta-analyses are paired mean and standard deviation of the sample or were converted into mean and SD of the sample from the following combinations: mean and standard error, median and interquartile range, or median and range (see appendix pp 9-10). Blue squares are mean estimates from each study with 95% confidence intervals. Diamonds represent the overall mean across studies for the common and random effect models. The random effect model accounts for within-study and between-study variance.CC BY · PubMed Central
Figure 4 Case Fatality Ratio (CFR) estimates (%) across outbreaks. Each panel corresponds to a different EVD outbreak, with the associated EV species in brackets. Points represent central estimates, with symbol shapes corresponding to analysis type: adjusted, naïve or unspecified. Thick coloured shaded lines represent the range of central estimates when the CFR was estimated, for example, across regions or over time. Solid coloured bars represent the uncertainty around the central estimates, reported in different formats including 95% CrIs and 95% CIs. All parameters are from articles with QA scores of >= 50% (see appendix pp 39-42).
Figure 4 Case Fatality Ratio (CFR) estimates (%) across outbreaks. Each panel corresponds to a different EVD outbreak, with the associated EV species in brackets. Points represent central estimates, with symbol shapes corresponding to analysis type: adjusted, naïve or unspecified. Thick coloured shaded lines represent the range of central estimates when the CFR was estimated, for example, across regions or over time. Solid coloured bars represent the uncertainty around the central estimates, reported in different formats including 95% CrIs and 95% CIs. All parameters are from articles with QA scores of >= 50% (see appendix pp 39-42).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 45

Metadata

Authors
Nash, R. K., Bhatia, S., Morgenstern, C., Doohan, P., Jorgensen, D., McCain, K., McCabe, R., Nikitin, D., Forna, A., Cuomo-Dannenburg, G., Hicks, J. T., Sheppard, R. J., Naidoo, T., van Elsland, S., Geismar, C., Rawson, T., Leuba, S. I., Wardle, J., Routledge, I., Fraser, K., Imai-Eaton, N., Cori, A., & Unwin, H. J. T.
Affiliations
  • Imperial College London (GB)
  • UK Health Security Agency (GB)
  • University of Liverpool (GB)
  • University of Georgia (US)
  • University of California, San Francisco (US)
  • University of Bristol (GB)
Corresponding author
Unwin, H Juliette T
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2024-12
Volume
24
Issue
12
Pages
e762-e773
ISSN
1473-3099 (ISSN-L)
OpenAlex
W4401381325
Cited by
35
References
44
Citations by year
2026: 21 · 2025: 11 · 2024: 3
FWCI
2.91
Type
journal article
Language
en
Locations
  • The Lancet Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (acceptedVersion, cc-by)
  • Explore Bristol Research (acceptedVersion, cc-by-nc-nd)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Wellcome Trust
  • The Schmidt Family Foundation
  • National Institute for Health Research Health Protection Research Unit
  • Academy of Medical Sciences
  • UKRI Medical Research Council
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
  • Physical Sciences › Mathematics › Applied Mathematics › Mathematical and Theoretical Epidemiology and Ecology Models
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords
Ebola virus disease, transmission model, epidemiological parameters, basic reproduction number, effective reproduction number, serial interval, incubation period, case fatality rate, Zaire ebolavirus, outbreak dynamics
MeSH terms
Disease Outbreaks, Humans, Models, Theoretical, Hemorrhagic Fever, Ebola, Ebolavirus, Basic Reproduction Number

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ebola virus disease mathematical models and epidemiological parameters: a systematic review. https://app.cochat.ai/papers/10.1016/s1473-3099(24)00374-8
The paper
Nash, R. K., Bhatia, S., Morgenstern, C., Doohan, P., Jorgensen, D., McCain, K., McCabe, R., Nikitin, D., Forna, A., Cuomo-Dannenburg, G., Hicks, J. T., Sheppard, R. J., Naidoo, T., van Elsland, S., Geismar, C., Rawson, T., Leuba, S. I., Wardle, J., Routledge, I., . . . Unwin, H. J. T. (2024). Ebola virus disease mathematical models and epidemiological parameters: a systematic review. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(24)00374-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.